The Crossroads of active Cancer and Thrombosis in COVID-19 era: a cumulative thrombotic risk

Expert: Nikolaos Tsoukalas, 401 General Military Hospital, Athens, Greece 1-What is the association between cancer and thrombosis? Why should we care? 2-What are the principles of thromboprophylaxis in oncology patients? (Guidelines and recommendations) 3-What are the main clinical features of coagulopathy in COVID-19 disease?  4-Is the cumulative thrombotic risk like a “perfect thrombotic storm” in oncology patients during COVID-19 pandemic?  5-Making clinical decisions regarding CAT management taking into consideration the potential cumulative thrombotic risk in COVID-19 era. Should oncologists modify their clinical practice?